Wesper Lab Achieves FDA Approval For At-Home Sleep Apnea Diagnosis

Sleep health platform can help 54 million Americans improve sleep quality from the comfort of their own bed with clinical accuracy

New York, NY, January 27, 2021: Wesper, the first of its kind sleep health platform,  today announced clearance by the U.S. Food and Drug Administration for its Wesper Lab system. The Wesper platform assists trained personnel in the diagnosis of sleep apnea with data from a wireless patch component the user can apply to their body in the comfort of their own bed.  

Sleep apnea is one of the most common sleep disorders in the United States with approximately 54 million adults suffering from the condition. Untreated sleep apnea increases the risk of dying from cardiovascular disease fivefold, as well as elevating the risk for cancer and Alzheimer’s disease. 

“Achieving FDA approval is an exciting and critical milestone to deliver on our mission to help everyone get better sleep,” said Dr. Reuveny, CEO and co-founder of Wesper. “COVID-19 caused a behavioral shift and widespread acceptance of at-home diagnostics as both patients and medical professionals sought quality solutions that deliver reliable results. This shift, coupled with our new FDA approval, helps to remove the most burdensome physical, scheduling and financial barriers that have traditionally challenged access to professional sleep diagnosis and treatment. We have the potential to improve  the sleep and ultimately overall health of millions of patients.” 

The Wesper Lab system was developed in close collaboration with practicing physicians, researchers and the nation’s leading sleep experts, bringing the highest levels of accuracy to people’s homes. The system includes:

  • The Test: Wesper has distilled the power of a sleep lab into an easy-to-use wireless patch, allowing anyone to be diagnosed remotely and receive treatment for their sleep issues with the guidance of a sleep specialist. 
  • Sleep Report: The 3-inch wireless patch tracks the patient’s breathing dynamics, respiration quality, body positions and an audio sample of snoring, distilling the data into a detailed sleep report.
  • Sleep Specialist: Wesper Lab connects the patient virtually to a sleep specialist who analyzes the sleep report and provides a personalized sleep plan with treatment options for better sleep.

“As a sleep medicine professional with 40 years’ experience conducting both clinical and research sleep studies, I find Wesper to be a quantum leap forward in providing an easy yet reliable way for people who are concerned about their sleep to be evaluated,” said Sonia Ancoli-Israel, Scientific Advisor. “Home sleep recordings continue to be the wave of the future and devices such as Wesper are moving the field of sleep medicine forward.” 

More than 15,000 people have turned to Wesper to get better sleep. The company anticipates a broader public launch of the FDA-approved version this summer.

Individuals looking to improve their sleep can experience a limited version of the product at: shop.wesper.co. Those interested in partnering with Wesper to bring the Wesper Lab system to their customers can contact hello@wesper.co

About Wesper:

For individuals who strive to live healthier lives, Wesper is at the forefront of health technology, providing users with the potential for better sleep through an innovative platform that integrates optimum comfort and virtual guidance. Wesper’s commitment to comfort, accessibility and technological advancement enables it to focus on building healthcare tools tailored to customers’ unique needs. Wesper has redefined sleep health by creating a seamless path to personalized solutions based on granular, clinical-grade data. Established in 2017 and headquartered in NY, as a spinout of Cornell Tech University, Wesper has recently received funding from leading VCs and employs nearly 20 distinguished professionals. Wesper is well on its way to achieving its mission to establishing a strong foundation for itself and is looking forward to improving the lives of billions around the globe.

###